Trinidad and Tobago

Trinidad and Tobago

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.51 (0.43 - 0.60) 2019 Modelled IHME
0.52 (0.44 - 0.60) 2018 Modelled IHME
0.53 (0.45 - 0.61) 2017 Modelled IHME
0.54 (0.46 - 0.61) 2016 Modelled IHME
0.54 (0.46 - 0.63) 2015 Modelled IHME
0.54 (0.46 - 0.63) 2014 Modelled IHME
0.55 (0.47 - 0.64) 2013 Modelled IHME
0.56 (0.47 - 0.65) 2012 Modelled IHME
0.57 (0.48 - 0.67) 2011 Modelled IHME
0.58 (0.49 - 0.68) 2010 Modelled IHME
0.59 (0.49 - 0.69) 2009 Modelled IHME
0.6 (0.50 - 0.70) 2008 Modelled IHME
0.61 (0.51 - 0.71) 2007 Modelled IHME
0.62 (0.51 - 0.72) 2006 Modelled IHME
0.63 (0.51 - 0.73) 2005 Modelled IHME
0.63 (0.52 - 0.74) 2004 Modelled IHME
0.63 (0.52 - 0.74) 2003 Modelled IHME
0.63 (0.52 - 0.75) 2002 Modelled IHME
0.64 (0.52 - 0.76) 2001 Modelled IHME
0.64 (0.52 - 0.77) 2000 Modelled IHME
0.64 (0.52 - 0.77) 1999 Modelled IHME
0.65 (0.53 - 0.77) 1998 Modelled IHME
0.66 (0.53 - 0.78) 1997 Modelled IHME
0.66 (0.53 - 0.78) 1996 Modelled IHME
0.66 (0.53 - 0.78) 1995 Modelled IHME
0.66 (0.53 - 0.78) 1994 Modelled IHME
0.66 (0.53 - 0.77) 1993 Modelled IHME
0.65 (0.53 - 0.76) 1992 Modelled IHME
0.64 (0.53 - 0.75) 1991 Modelled IHME
0.63 (0.52 - 0.74) 1990 Modelled IHME
1.26 (0.15 - 9.63) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.06 (0.04 - 0.08) 2018 Modelled IHME
0.06 (0.04 - 0.08) 2017 Modelled IHME
0.06 (0.04 - 0.08) 2016 Modelled IHME
0.06 (0.04 - 0.08) 2015 Modelled IHME
0.06 (0.04 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.08) 2013 Modelled IHME
0.07 (0.05 - 0.09) 2012 Modelled IHME
0.07 (0.05 - 0.09) 2011 Modelled IHME
0.07 (0.05 - 0.10) 2010 Modelled IHME
0.08 (0.06 - 0.11) 2009 Modelled IHME
0.09 (0.06 - 0.12) 2008 Modelled IHME
0.1 (0.07 - 0.13) 2007 Modelled IHME
0.11 (0.08 - 0.15) 2006 Modelled IHME
0.12 (0.08 - 0.17) 2005 Modelled IHME
0.15 (0.11 - 0.21) 2004 Modelled IHME
0.2 (0.14 - 0.28) 2003 Modelled IHME
0.25 (0.17 - 0.35) 2002 Modelled IHME
0.3 (0.20 - 0.41) 2001 Modelled IHME
0.32 (0.22 - 0.44) 2000 Modelled IHME
0.33 (0.22 - 0.45) 1999 Modelled IHME
0.34 (0.23 - 0.45) 1998 Modelled IHME
0.34 (0.23 - 0.46) 1997 Modelled IHME
0.34 (0.23 - 0.47) 1996 Modelled IHME
0.34 (0.23 - 0.47) 1995 Modelled IHME
0.34 (0.24 - 0.47) 1994 Modelled IHME
0.34 (0.24 - 0.46) 1993 Modelled IHME
0.34 (0.24 - 0.46) 1992 Modelled IHME
0.34 (0.24 - 0.46) 1991 Modelled IHME
0.34 (0.24 - 0.45) 1990 Modelled IHME
0.43 (0.05 - 3.53) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
7,637 (6,250 - 8,925) 1990 Modelled IHME
7,814 (6,422 - 9,158) 1991 Modelled IHME
7,970 (6,482 - 9,348) 1992 Modelled IHME
8,100 (6,575 - 9,527) 1993 Modelled IHME
8,204 (6,605 - 9,678) 1994 Modelled IHME
8,280 (6,609 - 9,788) 1995 Modelled IHME
8,318 (6,649 - 9,841) 1996 Modelled IHME
8,320 (6,731 - 9,841) 1997 Modelled IHME
8,302 (6,758 - 9,826) 1998 Modelled IHME
8,277 (6,748 - 9,863) 1999 Modelled IHME
8,266 (6,729 - 9,957) 2000 Modelled IHME
8,269 (6,799 - 9,830) 2001 Modelled IHME
8,274 (6,825 - 9,738) 2002 Modelled IHME
8,277 (6,846 - 9,726) 2003 Modelled IHME
8,272 (6,798 - 9,690) 2004 Modelled IHME
8,256 (6,752 - 9,703) 2005 Modelled IHME
8,215 (6,737 - 9,561) 2006 Modelled IHME
8,146 (6,739 - 9,460) 2007 Modelled IHME
8,058 (6,695 - 9,356) 2008 Modelled IHME
7,963 (6,637 - 9,268) 2009 Modelled IHME
7,872 (6,571 - 9,188) 2010 Modelled IHME
7,774 (6,502 - 9,007) 2011 Modelled IHME
7,660 (6,429 - 8,855) 2012 Modelled IHME
7,547 (6,357 - 8,751) 2013 Modelled IHME
7,453 (6,270 - 8,674) 2014 Modelled IHME
7,396 (6,259 - 8,639) 2015 Modelled IHME
7,378 (6,314 - 8,444) 2016 Modelled IHME
7,356 (6,191 - 8,452) 2017 Modelled IHME
7,267 (6,155 - 8,330) 2018 Modelled IHME
7,111 (5,915 - 8,304) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.89 (1.29 - 2.66) 2019 Modelled IHME
1.88 (1.25 - 2.62) 2018 Modelled IHME
1.86 (1.25 - 2.58) 2017 Modelled IHME
1.83 (1.26 - 2.56) 2016 Modelled IHME
1.8 (1.25 - 2.53) 2015 Modelled IHME
1.82 (1.30 - 2.49) 2014 Modelled IHME
1.9 (1.42 - 2.51) 2013 Modelled IHME
1.98 (1.54 - 2.52) 2012 Modelled IHME
2.14 (1.65 - 2.71) 2011 Modelled IHME
2.21 (1.72 - 2.81) 2010 Modelled IHME
2.23 (1.75 - 2.82) 2009 Modelled IHME
2.31 (1.80 - 2.93) 2008 Modelled IHME
2.15 (1.68 - 2.71) 2007 Modelled IHME
2.12 (1.66 - 2.66) 2006 Modelled IHME
2.17 (1.68 - 2.76) 2005 Modelled IHME
2.15 (1.70 - 2.72) 2004 Modelled IHME
2.13 (1.68 - 2.67) 2003 Modelled IHME
2.09 (1.66 - 2.63) 2002 Modelled IHME
2.11 (1.67 - 2.63) 2001 Modelled IHME
2.05 (1.61 - 2.56) 2000 Modelled IHME
2.26 (1.79 - 2.80) 1999 Modelled IHME
2.57 (2.07 - 3.13) 1998 Modelled IHME
2.62 (2.12 - 3.17) 1997 Modelled IHME
2.93 (2.39 - 3.55) 1996 Modelled IHME
2.93 (2.41 - 3.53) 1995 Modelled IHME
3.16 (2.60 - 3.83) 1994 Modelled IHME
3.21 (2.62 - 3.89) 1993 Modelled IHME
3.17 (2.58 - 3.85) 1992 Modelled IHME
3.21 (2.65 - 3.87) 1991 Modelled IHME
3.32 (2.73 - 3.97) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
26 (18 - 37) 2019 Modelled IHME
26 (17 - 36) 2018 Modelled IHME
26 (17 - 36) 2017 Modelled IHME
25 (17 - 35) 2016 Modelled IHME
25 (17 - 35) 2015 Modelled IHME
25 (18 - 34) 2014 Modelled IHME
26 (19 - 34) 2013 Modelled IHME
27 (21 - 34) 2012 Modelled IHME
29 (22 - 37) 2011 Modelled IHME
30 (23 - 38) 2010 Modelled IHME
30 (23 - 38) 2009 Modelled IHME
31 (24 - 39) 2008 Modelled IHME
29 (22 - 36) 2007 Modelled IHME
28 (22 - 35) 2006 Modelled IHME
29 (22 - 37) 2005 Modelled IHME
28 (22 - 36) 2004 Modelled IHME
28 (22 - 35) 2003 Modelled IHME
27 (22 - 34) 2002 Modelled IHME
27 (22 - 34) 2001 Modelled IHME
27 (21 - 33) 2000 Modelled IHME
29 (23 - 36) 1999 Modelled IHME
33 (26 - 40) 1998 Modelled IHME
33 (27 - 40) 1997 Modelled IHME
37 (30 - 45) 1996 Modelled IHME
37 (30 - 44) 1995 Modelled IHME
39 (32 - 48) 1994 Modelled IHME
40 (32 - 48) 1993 Modelled IHME
39 (32 - 47) 1992 Modelled IHME
39 (32 - 47) 1991 Modelled IHME
40 (33 - 48) 1990 Modelled IHME
68 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (18 - 34) 2019 Modelled IHME
25 (18 - 33) 2018 Modelled IHME
25 (18 - 33) 2017 Modelled IHME
25 (18 - 34) 2016 Modelled IHME
25 (19 - 34) 2015 Modelled IHME
26 (19 - 34) 2014 Modelled IHME
26 (19 - 35) 2013 Modelled IHME
27 (20 - 35) 2012 Modelled IHME
27 (21 - 36) 2011 Modelled IHME
28 (21 - 36) 2010 Modelled IHME
28 (21 - 36) 2009 Modelled IHME
28 (21 - 36) 2008 Modelled IHME
28 (21 - 36) 2007 Modelled IHME
28 (21 - 36) 2006 Modelled IHME
28 (21 - 36) 2005 Modelled IHME
28 (21 - 36) 2004 Modelled IHME
28 (21 - 36) 2003 Modelled IHME
28 (21 - 36) 2002 Modelled IHME
28 (21 - 37) 2001 Modelled IHME
28 (21 - 37) 2000 Modelled IHME
28 (21 - 37) 1999 Modelled IHME
28 (21 - 37) 1998 Modelled IHME
29 (21 - 37) 1997 Modelled IHME
29 (21 - 37) 1996 Modelled IHME
28 (21 - 37) 1995 Modelled IHME
28 (21 - 37) 1994 Modelled IHME
28 (21 - 37) 1993 Modelled IHME
28 (21 - 37) 1992 Modelled IHME
28 (21 - 37) 1991 Modelled IHME
28 (21 - 37) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
89 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
90 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
92 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
90 2011 Survey/reported WHO/UNICEF
90 2010 Survey/reported WHO/UNICEF
90 2009 Survey/reported WHO/UNICEF
90 2008 Survey/reported WHO/UNICEF
89 2007 Survey/reported WHO/UNICEF
89 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
76 2003 Survey/reported WHO/UNICEF
5 2002 Survey/reported WHO/UNICEF
93 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
% of substance use disorder facilities offering hepatitis testing
None
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.68 (1.35 - 2.08) 2019 Modelled IHME
1.66 (1.35 - 2.07) 2018 Modelled IHME
1.65 (1.34 - 2.06) 2017 Modelled IHME
1.63 (1.33 - 2) 2016 Modelled IHME
1.61 (1.31 - 1.98) 2015 Modelled IHME
1.6 (1.31 - 1.97) 2014 Modelled IHME
1.6 (1.30 - 1.97) 2013 Modelled IHME
1.59 (1.29 - 1.98) 2012 Modelled IHME
1.59 (1.29 - 1.98) 2011 Modelled IHME
1.59 (1.29 - 1.99) 2010 Modelled IHME
1.59 (1.29 - 1.99) 2009 Modelled IHME
1.59 (1.29 - 1.98) 2008 Modelled IHME
1.6 (1.30 - 1.98) 2007 Modelled IHME
1.6 (1.30 - 1.98) 2006 Modelled IHME
1.6 (1.30 - 1.98) 2005 Modelled IHME
1.6 (1.30 - 1.98) 2004 Modelled IHME
1.6 (1.30 - 1.98) 2003 Modelled IHME
1.6 (1.31 - 1.99) 2002 Modelled IHME
1.6 (1.30 - 1.99) 2001 Modelled IHME
1.6 (1.31 - 1.99) 2000 Modelled IHME
1.61 (1.32 - 2) 1999 Modelled IHME
1.63 (1.33 - 2.03) 1998 Modelled IHME
1.66 (1.36 - 2.06) 1997 Modelled IHME
1.69 (1.38 - 2.10) 1996 Modelled IHME
1.71 (1.39 - 2.13) 1995 Modelled IHME
1.72 (1.39 - 2.14) 1994 Modelled IHME
1.73 (1.40 - 2.14) 1993 Modelled IHME
1.74 (1.40 - 2.15) 1992 Modelled IHME
1.75 (1.40 - 2.17) 1991 Modelled IHME
1.75 (1.40 - 2.17) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
21,080 (16,824 - 26,139) 1990 Modelled IHME
21,209 (17,007 - 26,383) 1991 Modelled IHME
21,303 (17,148 - 26,334) 1992 Modelled IHME
21,363 (17,276 - 26,399) 1993 Modelled IHME
21,394 (17,320 - 26,563) 1994 Modelled IHME
21,409 (17,391 - 26,644) 1995 Modelled IHME
21,327 (17,398 - 26,432) 1996 Modelled IHME
21,124 (17,273 - 26,131) 1997 Modelled IHME
20,892 (17,061 - 25,960) 1998 Modelled IHME
20,718 (16,923 - 25,748) 1999 Modelled IHME
20,703 (16,875 - 25,724) 2000 Modelled IHME
20,804 (16,903 - 25,851) 2001 Modelled IHME
20,907 (17,043 - 25,929) 2002 Modelled IHME
21,006 (17,091 - 25,916) 2003 Modelled IHME
21,098 (17,150 - 26,084) 2004 Modelled IHME
21,182 (17,172 - 26,184) 2005 Modelled IHME
21,242 (17,242 - 26,286) 2006 Modelled IHME
21,275 (17,331 - 26,384) 2007 Modelled IHME
21,295 (17,289 - 26,493) 2008 Modelled IHME
21,327 (17,279 - 26,678) 2009 Modelled IHME
21,392 (17,346 - 26,851) 2010 Modelled IHME
21,496 (17,457 - 26,807) 2011 Modelled IHME
21,630 (17,563 - 26,862) 2012 Modelled IHME
21,785 (17,783 - 26,859) 2013 Modelled IHME
21,953 (17,896 - 26,996) 2014 Modelled IHME
22,127 (18,050 - 27,208) 2015 Modelled IHME
22,419 (18,303 - 27,619) 2016 Modelled IHME
22,757 (18,577 - 28,442) 2017 Modelled IHME
23,016 (18,751 - 28,663) 2018 Modelled IHME
23,243 (18,778 - 28,890) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.33 (2.28 - 4.77) 2019 Modelled IHME
3.26 (2.22 - 4.72) 2018 Modelled IHME
3.19 (2.21 - 4.50) 2017 Modelled IHME
3.11 (2.15 - 4.39) 2016 Modelled IHME
3 (2.09 - 4.21) 2015 Modelled IHME
2.89 (2.12 - 3.97) 2014 Modelled IHME
2.78 (2.11 - 3.69) 2013 Modelled IHME
2.66 (2.07 - 3.43) 2012 Modelled IHME
2.69 (2.08 - 3.48) 2011 Modelled IHME
2.73 (2.13 - 3.53) 2010 Modelled IHME
2.77 (2.18 - 3.56) 2009 Modelled IHME
2.9 (2.25 - 3.74) 2008 Modelled IHME
2.7 (2.11 - 3.46) 2007 Modelled IHME
2.67 (2.07 - 3.44) 2006 Modelled IHME
2.74 (2.12 - 3.54) 2005 Modelled IHME
2.74 (2.11 - 3.53) 2004 Modelled IHME
2.7 (2.10 - 3.47) 2003 Modelled IHME
2.64 (2.05 - 3.38) 2002 Modelled IHME
2.68 (2.09 - 3.48) 2001 Modelled IHME
2.59 (2.03 - 3.31) 2000 Modelled IHME
2.81 (2.22 - 3.57) 1999 Modelled IHME
3.03 (2.42 - 3.83) 1998 Modelled IHME
2.99 (2.38 - 3.75) 1997 Modelled IHME
3.27 (2.63 - 4.08) 1996 Modelled IHME
3.25 (2.62 - 4.04) 1995 Modelled IHME
3.51 (2.81 - 4.36) 1994 Modelled IHME
3.54 (2.85 - 4.40) 1993 Modelled IHME
3.49 (2.81 - 4.32) 1992 Modelled IHME
3.51 (2.82 - 4.34) 1991 Modelled IHME
3.65 (2.94 - 4.49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
46 (32 - 66) 2019 Modelled IHME
45 (31 - 65) 2018 Modelled IHME
44 (31 - 62) 2017 Modelled IHME
43 (30 - 61) 2016 Modelled IHME
41 (29 - 58) 2015 Modelled IHME
40 (29 - 54) 2014 Modelled IHME
38 (29 - 50) 2013 Modelled IHME
36 (28 - 47) 2012 Modelled IHME
36 (28 - 47) 2011 Modelled IHME
37 (29 - 48) 2010 Modelled IHME
37 (29 - 48) 2009 Modelled IHME
39 (30 - 50) 2008 Modelled IHME
36 (28 - 46) 2007 Modelled IHME
35 (27 - 46) 2006 Modelled IHME
36 (28 - 47) 2005 Modelled IHME
36 (28 - 47) 2004 Modelled IHME
35 (28 - 45) 2003 Modelled IHME
34 (27 - 44) 2002 Modelled IHME
35 (27 - 45) 2001 Modelled IHME
34 (26 - 43) 2000 Modelled IHME
36 (29 - 46) 1999 Modelled IHME
39 (31 - 49) 1998 Modelled IHME
38 (30 - 48) 1997 Modelled IHME
41 (33 - 51) 1996 Modelled IHME
41 (33 - 51) 1995 Modelled IHME
44 (35 - 54) 1994 Modelled IHME
44 (35 - 54) 1993 Modelled IHME
43 (34 - 53) 1992 Modelled IHME
43 (34 - 53) 1991 Modelled IHME
44 (35 - 54) 1990 Modelled IHME
29 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (17 - 31) 2017 Modelled IHME
23 (17 - 31) 2016 Modelled IHME
23 (16 - 31) 2015 Modelled IHME
23 (17 - 31) 2014 Modelled IHME
23 (17 - 30) 2013 Modelled IHME
23 (16 - 30) 2012 Modelled IHME
23 (16 - 30) 2011 Modelled IHME
23 (16 - 30) 2010 Modelled IHME
23 (16 - 30) 2009 Modelled IHME
23 (16 - 30) 2008 Modelled IHME
23 (16 - 30) 2007 Modelled IHME
23 (16 - 31) 2006 Modelled IHME
23 (16 - 30) 2005 Modelled IHME
23 (16 - 31) 2004 Modelled IHME
23 (16 - 30) 2003 Modelled IHME
23 (16 - 31) 2002 Modelled IHME
23 (16 - 31) 2001 Modelled IHME
24 (17 - 31) 2000 Modelled IHME
23 (16 - 31) 1999 Modelled IHME
23 (16 - 30) 1998 Modelled IHME
23 (16 - 30) 1997 Modelled IHME
23 (16 - 31) 1996 Modelled IHME
23 (16 - 31) 1995 Modelled IHME
24 (17 - 31) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
24 (17 - 31) 1992 Modelled IHME
24 (16 - 31) 1991 Modelled IHME
23 (16 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
% of substance use disorder facilities offering hepatitis testing
None
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.51 (%)
2019
(0.43 - 0.6(%))
IHME
HCV (RNA/cAg+)
1.68 (%)
2019
(1.35 - 2.08(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
26
2019
(18 - 37)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
46
2019
(32 - 66)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.06 (%)
2019, latest modelled
(0.04 - 0.08(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources